'At the stage where we are in today in the country, by the time mass vaccination becomes available, it would be around the middle of next year.' 'Most of those people, who got infected this year, will be next year back to level zero -- once again susceptible.'
The prime minister, who is visiting the US at the invitation of President Biden and First Lady Jill Biden, will join them for the state banquet along with a number of dignitaries on Thursday.
'Prevention plus vaccination is what is going to take us into better territory by September or October.'
During the webinar, 'COVID-19: Vaccination and Potential Return to Normalcy - If and When', Dr Hotez, an internationally-recognised physician-scientist in neglected tropical diseases and vaccine development, said that the COVID-19 vaccine rollout is "India's gift' to the world in combating the virus.
Images that capture what it was like living through 2021.
History shows us that even effective vaccines could have unknown side effects that could develop over time, warns former Cabinet Secetary K M Chandrasekhar.
The first nationwide mock drill was held on January 2 which, the health ministry said, helped to iron out any glitches in the final execution and further refinement of the operational procedures.
'The Union government has discouraged state and local governments from imposing restrictions on their own.' 'That advice should be withdrawn,' asserts Mihir S Sharma.
'Ideally, the efficacy data of all the trials should be there in the public domain, and as soon as possible.' 'It is difficult to understand the reason behind the authorisation.'
The vaccine candidate, ZyCoV-D, showed a "strong immune response" in animal studies, and the antibodies produced were able to completely neutralise the wild type virus, Zydus said. The 12 institutes have been asked by the ICMR to fast track clinical trials of the vaccine as it is being considered as one of the top priority projects which are being monitored at the topmost level of the government.
A steady decline in new COVID-19 cases has been recorded in India for the last 20 days, with 24 states witnessing a dip in active cases since the last week, the Union health ministry said.
The endemic stage is when a population learns to live with a virus.
Unless public health is prioritised over swift re-opening, the chances are that a third wave will hit India sooner than we would like.
The NTAGI has also stated that those having laboratory test proven SARS-CoV-2 illness should defer COVID-19 vaccination for six months after recovery, the sources said.
'Whenever you roll out: effectiveness is important, operational logistics are important, side effects are important and vaccine hesitancy is important.'
Students who have received admission to foreign universities are struggling with unexpected delays, additional living costs and scarcity of vaccine supplies.
'The future looks quite bleak unless we ramp up testing and start vaccinating on a war footing.'
'There is a Covid vaccine-mania that is happening in the world now and the vaccine makers are using this mania for their own gains'
'Even after vaccines are given, precautions like using a mask and maintaining social distancing have to be taken.'
'We are going ahead with the trials assuming what we have is the vaccine.' 'There is also a chance that what you have is not the vaccine. Then, you have to go back to the drawing board again.' 'So far, there has been no success in developing a good vaccine against coronaviruses.' 'That's why there are hundreds of trials going on at different stages in different parts of the world.'
'This is a tragedy that must be stopped.'
India is in the midst of its biggest crisis since Independence. It is a national emergency and begs to be dealt with. Politics can wait. Lives need to be saved. We need to vaccinate India at a pace faster than any country in the world, asserts Ramesh Menon.
Ajit Mishra, vice president, Research, Religare Broking, answers your queries.
Ajit Mishra, vice president, Research, Religare Broking, answers your queries.
Vinod Kumar, Tata Communication CEO has amazing business strategies to enhance topline.
Ajit Mishra, Vice President, Research, Religare Broking, answers readers's queries on stocks they own or want to buy.
© 2026 Rediff.com - Investor Information - Advertise with us - Disclaimer - Privacy Policy - Sitemap - Feedback - About us - Terms of use - Grievances